Zoetis | ZTS - Sales Revenues

Stock Price
115.00
Daily Change
1.17 1.03%
Monthly
-2.72%
Yearly
-26.12%
Q2 Forecast
114.37

Zoetis reported $2.4B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 15B 1.62B Mar/2026
Align Technology USD 1.04B 10M Mar/2026
Bayer EUR 11.44B 1.78B Dec/2025
Bristol-Myers Squibb USD 11.49B 1.01B Mar/2026
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Eli Lilly USD 19.8B 500M Mar/2026
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Illumina USD 1.09B 70M Mar/2026
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.1B 500M Mar/2026
Laboratory Of America USD 3.54B 20M Mar/2026
Merck USD 16.29B 110M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
Pacira USD 177M 19.87M Mar/2026
Perrigo USD 1.11B 70M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Sanofi EUR 11.24B 60M Mar/2026
Sanofi EUR 12.14B 65M Mar/2026
Zoetis USD 2.4B 0 Dec/2025